Assay Detail

CHEMBL869618

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Functional

Antiviral activity against multi PI resistant HIV1 EP14 in MT4 cells

ChEMBL ↗

Free Research Context This assay will appear in recent viewed items on this browser. Open the demo workspace to preview project-only review queues.

Research home Demo workspace

Target

MT4 (CHEMBL388) ↗

Open DB target context

Use one target anchor to keep assay intent, target linkage, and tested compound review aligned.

Loading context

MT4 (CHEMBL388) is the working anchor for this assay review. Loading the live Open DB target snapshot…

Primary target MT4

CHEMBL388

Anchored from Assay target.

Protein identity MT4

Disease frame Disease evidence pending

Open the live target snapshot or evidence card before reviewing assay metadata so target fit and disease framing stay reusable.

Review focus Open DB context pending

Open the live target snapshot before relying on this target frame across surface handoff.

Open target snapshot Open evidence card Search with this context

Total Activities

Compounds Tested

Activity Types

Assay Parameters

Assay Information

Assay Type	Functional
Cell Type	MT4
Confidence	1 — Organism
Curated By	Expert

Target

MT4 (CHEMBL388) ↗

Type	CELL-LINE
Organism	Homo sapiens

Publication

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

Miller JF, Andrews CW, Brieger M, Furfine ES, Hale MR, Hanlon MH, Hazen RJ, Kaldor I, McLean EW, Reynolds D, Sammond DM, Spaltenstein A, Tung R, Turner EM, Xu RX, Sherrill RG.
Bioorg Med Chem Lett (2006) 16 : 1788 -1794
PubMed 16458505 · DOI

Activity Statistics

Type	Count	Avg pChEMBL	Best pChEMBL
IC50	1	9.11	9.11

Compounds Tested

Compound	Name	Phase	Activities	Best pChEMBL
CHEMBL206031	BRECANAVIR	2.0	1	9.11

Activity Data

Compound	Name	Type	Rel.	Value	Units	pChEMBL
CHEMBL206031	BRECANAVIR	IC50	=	0.77	nM	9.11